VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 115 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $703,000 | -16.6% | 62,784 | -37.7% | 0.00% | -25.0% |
| Q1 2016 | $843,000 | -10.1% | 100,784 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $938,000 | -17.5% | 100,784 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $1,137,000 | -11.1% | 100,784 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $1,279,000 | +36.5% | 100,784 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $937,000 | -68.3% | 100,784 | -52.5% | 0.00% | -69.2% |
| Q4 2014 | $2,960,000 | +34.4% | 212,184 | 0.0% | 0.01% | +44.4% |
| Q3 2014 | $2,202,000 | -39.3% | 212,184 | -5.3% | 0.01% | -40.0% |
| Q2 2014 | $3,625,000 | +129.4% | 224,047 | +130.4% | 0.02% | +150.0% |
| Q1 2014 | $1,580,000 | – | 97,226 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |